The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.
The genetic testing results also inform patients’ family members about their cancer risks so they can be proactive in screening and prevention. For now, GENETECA™ is only available to people with ...
AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...
A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to ...
The NHS has launched a new genetic blood test to improve the safety of kidney donations from people of Black African and ...
The federal government vows to ban life insurers from using genetic testing results to refuse cover or hike premiums, but ...
“At AEON Clinic, we bridge the gap between science and health. Genomic insights allow us to address health risks at their ...
Hundreds of potential kidney donors of Black African and Black Caribbean heritage in the UK can now get a simple blood test to help reduce the risk of kidney failure.
Significant racial disparities persisted in genetic testing for inborn errors of immunity despite the removal of financial barriers, according to a study published in The Journal of Allergy and ...